Education
About Us
Working with TipRanks
Follow Us
Eric A Hughes Insider Profile
4 Followers
Eric A Hughes, EVP, Global R&D and Chief Medical Officer at Teva Pharmaceutical, holds 0.00 shares in Teva Pharmaceutical (Ticker: TEVA), holds ― shares in Monte Rosa Therapeutics (Ticker: GLUE).
Eric A Hughes has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Eric A Hughes does not currently own shares as a corporate insider.
A breakdown of Eric A Hughes's holdings
Insider Roles
Roles that Eric A Hughes holds in companies
Most Profitable Insider Trade
The most profitable trade made by Eric A Hughes
Eric A Hughes's Trading History
Teva Pharmaceutical
Mar 06, 2025
EVP, Global R&D and Chief Medical Officer
Uninformative Buy
364.81K
$0.00
Monte Rosa Therapeutics
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Eric A Hughes's performance on stock
You May Also Like
Eric A Hughes insider profile FAQ
What is the percentage of profitable transactions made by Eric A Hughes?
The percentage of profitable transactions made by Eric A Hughes is ―.
What is the average return per transaction made by Eric A Hughes?
The average return per transaction made by Eric A Hughes is ―.
What stocks does Eric A Hughes hold?
Eric A Hughes holds: TEVA, GLUE stocks.
What was Eric A Hughes’s latest transaction?
Eric A Hughes latest transaction was an Uninformative Buy of $364.81K.
What was Eric A Hughes's most profitable transaction?
Eric A Hughes’s most profitable transaction was an Informative Sell of TEVA stock on August 13, 2024. The return on the trade was 10.30%.
What is Eric A Hughes's role in Teva Pharmaceutical?
Eric A Hughes's role in Teva Pharmaceutical is EVP, Global R&D and Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.